DOI: 10.12890/2024_004709

Polymyalgia rheumatica during the course of limited cutaneous scleroderma: an unusual and challenging coexistence

Authors

  • Noel Lorenzo-Villalba Service de Médecine Interne, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
  • Charlene Habib Service de Médecine Interne, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
  • Léa Docquier Service de Médecine Interne, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
  • Edward Nasco Service de Médecine Interne, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
  • Alessio Imperiale Service de Médicine Nucléaire, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
  • Emmanuel Andrès Service de Médecine Interne, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
  • Jean Edouard Terrade Service de Médecine Interne, Hôpitaux Universitaires de Strasbourg, Strasbourg, France

noellorenzo@gmail.com

Keywords

Polymyalgia rheumatica, scleroderma

Abstract

A 50-year-old patient with a history of limited cutaneous scleroderma began with polyarthralgia (left shoulder, elbows and hips) without stiffness or associated inflammatory syndrome. Treatment with oral anti-inflammatory drugs was started on suspicion of peripheral spondyloarthritis with partial response. This progressed with the appearance of stiffness and functional limitation of the hips as well as an increase in the inflammatory syndrome two weeks after onset. It was decided to perform an 18F-FDG-PET scan compatible with polymyalgia rheumatica. The patient was treated with oral corticosteroids with an excellent response after one week of treatment.

View the entire article

Downloads

References

  1. Orzano IM, Lally EV. Development of polymyalgia rheumatica in patients with scleroderma. J Rheumatol 2006;33:1206–1207.
  2. Serrano-Combarro A, Prieto-Peña D, Martínez-Rodríguez I, Martínez-Amador N, Loricera J, Blanco R. The usefulness of 18F-FDG-PET/CT in detecting musculoskeletal and vascular involvement in patients with polymyalgia rheumatica receiving glucocorticoids. Eur J Intern Med 2024;124:78–83.
  3. Prieto-Pena D, Martínez-Rodríguez I, Loricera J, Banzo I, Calderón-Goercke M, Calvo-Río V, et al. Predictors of positive 18F-FDG PET/CT scan for large vessel vasculitis in patients with persistent polymyalgia rheumatica. Semin Arthritis Rheum 2019;48:720–727.
  4. Rosenberg H, Halman S, Yadav K. Polymyalgia rheumatica. CMAJ 2021;193:E1770.
  5. Lóránd V, Czirják L, Minier T. Musculoskeletal involvement in systemic sclerosis. Presse Med 2014;43:e315–328.
  6. Sari-Kouzel H, Herrick AL, Freemont AJ, Marcuson RW, Jayson MI. Giant cell arteritis in a patient with limited cutaneous systemic sclerosis. Rheumatology (Oxford) 1999;38:479–480.

Published

2024-07-01

How to Cite

1.
Lorenzo-Villalba N, Habib C, Docquier L, Nasco E, Imperiale A, Andrès E, et al. Polymyalgia rheumatica during the course of limited cutaneous scleroderma: an unusual and challenging coexistence. EJCRIM [Internet]. 2024 Jul. 1 [cited 2026 Nov. 3];11(7). Available from: https://ejcrim.com/index.php/ejcrim/article/view/4709

Most read articles by the same author(s)

1 2 > >>